🇺🇸 FDA
Patent

US 6750026

Screening methods using ligands of the neutropeptide receptor HFGAN72

expired A61KA61K38/00A61P

Quick answer

US patent 6750026 (Screening methods using ligands of the neutropeptide receptor HFGAN72) held by The Board of Regents of the University of Texas System expires Mon Jun 10 2024 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Jun 15 2004 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 10 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
2
CPC classes
A61K, A61K38/00, A61P, A61P13/02, A61P15/00